Advertisement
UK markets open in 2 hours 31 minutes

  • NIKKEI 225

    38,768.32
    +532.25 (+1.39%)
     

  • HANG SENG

    18,420.38
    -157.92 (-0.85%)
     

  • CRUDE OIL

    78.71
    +0.23 (+0.29%)
     

  • GOLD FUTURES

    2,332.50
    +1.30 (+0.06%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • Bitcoin GBP

    50,473.82
    -437.13 (-0.86%)
     

  • CMC Crypto 200

    1,360.47
    +47.84 (+3.65%)
     

  • NASDAQ Composite

    16,349.25
    +192.92 (+1.19%)
     

  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     

Darden Restaurants (DRI) in Focus: Stock Moves 6.8% Higher

Zacks Equity Research
Updated

Darden Restaurants, Inc. DRI was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 16.8% in the past one-month time frame.

The move came after the company reported better-than-expected second-quarter fiscal 2018 results.

The company has seen four positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Darden Restaurants. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Darden Restaurants currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

ADVERTISEMENT

Darden Restaurants, Inc. Price

Darden Restaurants, Inc. Price | Darden Restaurants, Inc. Quote

Investors interested in the Retail - Restaurants industry may consider Famous Dave's of America, Inc. DAVE, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is DRI going up? Or down? Predict to see what others think:Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Darden Restaurants, Inc. (DRI) : Free Stock Analysis Report
 
Famous Dave's of America, Inc. (DAVE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research